Skip to content
AlgaeMed Industries

AlgaeMed Industries

The Bioengineering Enterprise

  • Home
  • Company
    • Overview
    • Management Team
      • Hugo P. Sondermeijer, M.D., Ph.D., M.Sc.
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Research & Development Supplies
      • HyperPure Unmodified Alginate Liquid Solutions
      • HyperPure Modified Alginate Liquid Solutions
      • HyperPure Unmodified 3D Alginate Solid Scaffolds
      • Hyperpure Modified 3D Alginate Solid Scaffolds
      • HyperPure Unmodified Alginate Powders
      • HyperPure Modified Alginate Powders
    • Clinical Development Supplies
      • HyperPure Alginate Gauzes
    • Cardiovascular Diseases
    • Metabolic Diseases
    • Wound Healing
    • Clinical Trials
  • Science
    • Purified Sodium Alginate
    • Purified Modified Sodium Alginate
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Investors
    • At A Glance
    • Company Announcements
    • Share Price and Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities
  • Hugo P. Sondermeijer, M.D., Ph.D., M.Sc.
  • Ben Sprangers, M.D., Ph.D., M.B.A.
  • Goda Choy, M.D., Ph.D., M.B.A.
  • Mark. A. Hardy, M.D.

At A Glance

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
Like Loading...
2026 AlgaeMed Industries
Website Powered by WordPress.com.
  • Subscribe Subscribed
    • AlgaeMed Industries
    • Already have a WordPress.com account? Log in now.
    • AlgaeMed Industries
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d